Homepage
Open in app
Sign in
Get started
Market access insights in our own words — Entrée Health and Valuate Health Consultancy.
Product Value
Health Economics
Policy and Procedure
Population Health
Follow
CMS arms Medicaid with a new drug payment program
CMS arms Medicaid with a new drug payment program
Value-based purchasing elevates state contracts for manufacturers
Valuate Health Consultancy
Dec 22, 2020
Provider visits return to pre-pandemic level for some specialties
Provider visits return to pre-pandemic level for some specialties
Valuate Health Consultancy reviewed recent report to identify key takeaways that may affect strategic thinking for manufacturers
Valuate Health Consultancy
Oct 22, 2020
Diverse COVID-19 vaccines advance toward market
Diverse COVID-19 vaccines advance toward market
The strategies, pricing, and prioritization behind COVID-19 vaccine contenders allow for unparalleled development speed
Valuate Health Consultancy
May 27, 2020
Managing conflicting cancer care preferences during COVID
Managing conflicting cancer care preferences during COVID
Divergence exists between providers who embrace home infusion of chemotherapy and those refuse to even consider it.
Valuate Health Consultancy
Apr 16, 2020
CAR T Conundrum: Reimbursement Shadows Clinical Value
CAR T Conundrum: Reimbursement Shadows Clinical Value
Although CAR T-cell therapy offers new promise, high costs, cash flow issues, and lack of real-world evidence have stunted product uptake
Valuate Health Consultancy
Feb 4, 2020
Include patients, improve outcomes
Include patients, improve outcomes
The impact of patient-reported outcomes (PROs) on improving quality is a recent but rapidly advancing story
Valuate Health Consultancy
Jan 8, 2020
About This Way In
Latest Stories
Archive
About Medium
Terms
Privacy
Teams